GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Shiller PE Ratio

Ipca Laboratories (BOM:524494) Shiller PE Ratio : 42.10 (As of Apr. 12, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Shiller PE Ratio?

As of today (2025-04-12), Ipca Laboratories's current share price is ₹1331.70. Ipca Laboratories's E10 for the quarter that ended in Dec. 2024 was ₹31.63. Ipca Laboratories's Shiller PE Ratio for today is 42.10.

The historical rank and industry rank for Ipca Laboratories's Shiller PE Ratio or its related term are showing as below:

BOM:524494' s Shiller PE Ratio Range Over the Past 10 Years
Min: 41.05   Med: 48.95   Max: 54.8
Current: 42.1

During the past years, Ipca Laboratories's highest Shiller PE Ratio was 54.80. The lowest was 41.05. And the median was 48.95.

BOM:524494's Shiller PE Ratio is ranked worse than
79.05% of 525 companies
in the Drug Manufacturers industry
Industry Median: 23.25 vs BOM:524494: 42.10

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ipca Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹9.780. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹31.63 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ipca Laboratories Shiller PE Ratio Historical Data

The historical data trend for Ipca Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Shiller PE Ratio Chart

Ipca Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ipca Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 47.88 53.54

Competitive Comparison of Ipca Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Shiller PE Ratio falls into.


;
;

Ipca Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ipca Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1331.70/31.63
=42.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipca Laboratories's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Ipca Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=9.78/158.3229*158.3229
=9.780

Current CPI (Dec. 2024) = 158.3229.

Ipca Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200603 0.000 45.521 0.000
200703 0.000 48.581 0.000
200803 0.000 52.407 0.000
200903 0.000 56.615 0.000
201003 0.000 65.030 0.000
201103 0.000 70.768 0.000
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 2.715 111.317 3.861
201809 4.691 115.142 6.450
201812 6.299 115.142 8.661
201903 3.900 118.202 5.224
201906 5.120 120.880 6.706
201909 7.640 123.175 9.820
201912 7.815 126.235 9.801
202003 3.386 124.705 4.299
202006 17.620 127.000 21.966
202009 10.555 130.118 12.843
202012 5.230 130.889 6.326
202103 6.359 131.771 7.640
202106 12.090 134.084 14.276
202109 9.860 135.847 11.491
202112 7.760 138.161 8.892
202203 5.140 138.822 5.862
202206 5.640 142.347 6.273
202209 5.670 144.661 6.205
202212 4.250 145.763 4.616
202303 3.020 146.865 3.256
202306 6.420 150.280 6.764
202309 5.720 151.492 5.978
202312 7.090 152.924 7.340
202403 2.340 153.035 2.421
202406 7.580 155.789 7.703
202409 9.050 157.882 9.075
202412 9.780 158.323 9.780

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ipca Laboratories  (BOM:524494) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Ipca Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories Headlines

No Headlines